Amplia Therapeutics Ltd.ASX: ATX

Ethics Clearance Phase 2 Trial - Pancreatic Cancer Patients

Apr 6, 2022 at 5:23 AM UTC · Issued by Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd has released a press release.

View Attachment